Explore opportunities in mastering MENA's generic CTD submissions with expert-led insights. Harness regional expertise to streamline processes, minimize delays, and align with global strategies for ...
The US Food and Drug Administration (FDA) has announced that starting on 1 October 2026, manufacturers must submit adverse event individual case safety reports (ICSRs) for drugs, biologics, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results